GLOBALink | Why foreign companies increase investment in China-Novo Nordisk
Updated: October 28, 2022 Source: Xinhua News Agency
Over the past 20 years, Novo Nordisk, a pharmaceutical company from Denmark, has continuously expanded its investment in its facility in north China's Tianjin Municipality to boost its local presence and better serve patients in China and worldwide.
Over the past 20 years, Novo Nordisk, a pharmaceutical company from Denmark, has continuously expanded its investment in its facility in north China's Tianjin Municipality to boost its local presence and better serve patients in China and worldwide.
Produced by Xinhua Global Service
Editor: Li Shimeng
